Drug Type CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CDH3 inhibitors(Cadherin 3 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Prostate Carcinoma | Preclinical | Japan | 29 Apr 2025 | |
Metastatic Prostate Carcinoma | Preclinical | United States | 29 Apr 2025 | |
Metastatic Triple-Negative Breast Carcinoma | Preclinical | Japan | 29 Apr 2025 | |
Metastatic Triple-Negative Breast Carcinoma | Preclinical | United States | 29 Apr 2025 |